期刊文献+

Drosha在子宫内膜癌组织中的差异表达及临床意义 被引量:4

Clinical significance of differential Drosha expression between endometrial cancer tissue and other tissues
下载PDF
导出
摘要 目的探讨Drosha在子宫内膜癌组织中的表达及临床意义。方法应用实时荧光定量PCR(q RT-PCR)和Western blot检测正常子宫内膜组织(25例)、不典型增生子宫内膜组织(20例)及子宫内膜癌组织(40例)中Drosha的表达,分析Drosha在子宫内膜癌组织中的表达与临床病理因素之间的关系。结果子宫内膜癌组Drosham RNA及蛋白表达水平均低于不典型增生子宫内膜组及正常子宫内膜组(均P<0.05),不典型增生子宫内膜组及正常子宫内膜组的表达差异无统计学意义(均P>0.05)。不同年龄、组织分级、病理分型、淋巴结转移、肌层浸润深度和FIGO分期的子宫内膜癌患者的Drosha m RNA表达差异无统计学意义(均P>0.05)。结论 Drosha在子宫内膜癌组织中表达下调,可能与子宫内膜癌的发生发展有关。 Objective To detect the different expressions of Drosha between endometrial cancer (EC) tissue and other tissues and to explore correlation between Drosha mRNA transcription level and protein expression level with clinicopatho?logical characteristics of EC. Methods The mRNA transcription and protein expression levels of Drosha were examinaned by q-PCR and Western blot respectively in normal endometrial tissues (25 cases), atypical hyperplasia of endometrial tis?sues (20 cases) and endometrial cancer tissues (40 cases). Correlations between Drosha mRNA transcription and protein ex?pression with clinicopathological characteristics of EC were analyzed. Results The levels of Drosha mRNA and protein lev?els in EC were obviously lower than those in endometrial atypical hyperplasia and normal endometrium (P〈0.05). But there is no significant difference of Drosha expression between endometrial atypical hyperplasia and normal endometrium tissues (P〉0.05). The protein expression levels of Drosha were consistent with transcription of mRNA transcription levels. Drosha mRNA expression does not differ significantly with differentiation, histological type, myometrial invasion, lymphatic metasta?sis and FIGO stages of EC (P〉0.05). Conclusion The expression levels of Drosha in EC tissues were down-regulated, therefore the reduction of Drosha may contributed to tumorigenesis of EC.
出处 《天津医药》 CAS 2015年第4期383-385,共3页 Tianjin Medical Journal
基金 广西科技攻关计划项目(1298003-2-2)
关键词 子宫内膜癌 印迹法 蛋白质 DROSHA 实时荧光定量PCR 临床病理特征 endometrial cancer blotting, Western Drosha quantitative real-time polymerase chain reaction clinicopathological feature
  • 相关文献

同被引文献53

  • 1Hogberg T, Signorelli M, Deoliveira C F, et al.Sequent ialadjuvantchemotherapy and radiotherapy in endometrial cancerresults from tworandomised studies[J].Eur J Cancer, 2010,46(20): 2422-2431.
  • 2Slomovitz B M, Lu K H, Johnston T, et al.A phase 2 study of the oralmammalian target of rapamycin inhibitor, everolimus, in patients withrecurrent endometrial carcinoma[J].Cancer, 2010,9(116): 5415-5419.
  • 3Covens A L, Filiaci V,Gersell D, et al.Phase II study of fulvestrantinrecurrent/metastatic endometrial carcinoma: a Gynecologic Oncology.Group study[J].Gynecol Oncol, 2011,27(120): 185-188.
  • 4Morice P, Leary A, Creutzberg C, et al. Endometrial cancer [ J ]. Lan- cet,2015,384(4) :431-437.
  • 5Ameres SL,Zamore PD. Diversifying microRNA sequence and function [J]. Nat Rev Mol Cell Biol,2013,14(8) :475488.
  • 6Siegel R, Naishadham D, Jemal A. Cancer statistics,2013 [J]. CACan- cer J Clin ,2013,63 ( 1 ) : 11-30.
  • 7Avery-Kiejda KA, Braye SG, Forbes JF, et al. The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metas-tases in triple negative breast cancer[ J]. BMC Cancer,2014,14:253.
  • 8Shu GS, Yang ZL, Liu DC. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gall-bladder and their clinicopathological significances [ J ]. Pathol Res Pract, 2012,208(7) :392-397.
  • 9Jafamejad SM, Sjoestroem C, Martinka M, et al. Expression of the RNase Ill enzyme DROSHA is reduced during progression of hu-man cutaneous melanoma [ J ]. Mod Pathol,2013,26 (7) :902-910.
  • 10Corcoran C, Rani S, O' Driscoll L. miR-34a is an intracellular and exo- somal predictive biomarker for response to docetaxel with clini-cal rel- evance to prostate cancer progression [ J ]. Prostate, 2014,34 ( 5 ) : 1320-1334.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部